BlackRock Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$824K Sell
185,952
-3,422
-2% -$14.4K ﹤0.01% 1956
2016
Q3
$884K Buy
189,374
+90,164
+91% +$534K ﹤0.01% 1888
2016
Q2
$652K Buy
99,210
+67,802
+216% +$479K ﹤0.01% 1982
2016
Q1
$200K Buy
31,408
+1,982
+7% +$10.2K ﹤0.01% 2550
2015
Q4
$177K Sell
29,426
-13,577
-32% -$77.6K ﹤0.01% 2639
2015
Q3
$257K Sell
43,003
-105,580
-71% -$733K ﹤0.01% 2587
2015
Q2
$1.02M Sell
148,583
-189,241
-56% -$1.2M ﹤0.01% 1653
2015
Q1
$2.05M Buy
337,824
+11,116
+3% +$74K ﹤0.01% 1217
2014
Q4
$2.26M Buy
326,708
+100,920
+45% +$742K ﹤0.01% 1164
2014
Q3
$1.84M Buy
225,788
+186,858
+480% +$1.46M ﹤0.01% 1196
2014
Q2
$317K Sell
38,930
-4,714
-11% -$35.8K ﹤0.01% 2346
2014
Q1
$342K Buy
43,644
+2,342
+6% +$19.8K ﹤0.01% 2325
2013
Q4
$366K Buy
41,302
+3,389
+9% +$30.3K ﹤0.01% 2271
2013
Q3
$318K Buy
37,913
+2,523
+7% +$20.4K ﹤0.01% 2245
2013
Q2
$264K Buy
+35,390
New +$271K ﹤0.01% 2299

Other funds holding SPPI

BlackRock Advisors's SPPI Position: Q4 2016 in Review

BlackRock Advisors reduced its Spectrum Pharmaceuticals Inc (SPPI) stake by 1.8% in Q4 2016, selling an estimated $14.4K and leaving 185,952 shares worth $824K. The position accounts for ﹤0.01% of the portfolio, ranked #1956.

BlackRock Advisors first reported a position in SPPI in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.26M in Q4 2014. 139 funds tracked by Wall St. Rank hold SPPI as of Q4 2016.

  • BlackRock Advisors held 185,952 shares of Spectrum Pharmaceuticals Inc worth $824K as of Q4 2016.
  • BlackRock Advisors sold 3,422 Spectrum Pharmaceuticals Inc shares in Q4 2016, an estimated $14.4K.
  • Spectrum Pharmaceuticals Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1956 holding.
  • BlackRock Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Spectrum Pharmaceuticals Inc position peaked at $2.26M in Q4 2014.
  • 139 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.